Next Article in Journal
Is the Gap Between Micro- and Macroeconomic Assessments in Health Care Well Understood? The Case of Vaccination and Potential Remedies
Previous Article in Journal
New Drug Regulations in France: What Are the Impacts on Market Access? Part 1—Overview of New Drug Regulations in France
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JMAHP
Volume 2
Issue 1
10.3402/jmahp.v2.25302
jmahp-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Pharmaceutical Market Access in Emerging Markets: Concepts, Components, and Future

by
Anuj Kumar
,
Karthaveerya Juluru
*,
Phani Kishore Thimmaraju
*,
Jayachandra Reddy
and
Anand Patil
phamax Analytical Resource Pvt. Ltd., #19, ‘KMJ Ascend’, 1st Cross, 17th C Main, 5th Block, Koramangala, Bangalore 560 095, India
*
Authors to whom correspondence should be addressed.
J. Mark. Access Health Policy 2014, 2(1), 25302; https://doi.org/10.3402/jmahp.v2.25302
Submission received: 24 July 2014 / Revised: 3 November 2014 / Accepted: 3 November 2014 / Published: 1 December 2014

Abstract

This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets. Market access has gained considerable attentionworldwide as countries try to contain their escalating healthcare expenditures amidst the global economic slowdown. This has resulted in governments adopting stricter measures for new product approval. Thus, pharmaceutical companies are finding it increasingly difficult to successfully address the specific challenges posed by various government and regulatory agencies and stakeholders. There is an increasing need to establish market access functions, especially in emerging markets, where the complex, dynamic healthcare landscape confounds product approval and uptake. Moreover, emerging markets are the engines of growth today, and, thus, performing in these markets is critical for the majority of pharmaceutical companies. To address the challenges posed by regulatory agencies and diverse stakeholders, a customized market access strategy is the need of the hour. A market access framework with specific tools and tactics will help companies to plan, implement, and monitor stakeholder engagement activities.
Keywords: pharmaceutical market access; emerging markets; developed markets; stakeholders; market access framework; escalating healthcare cost; pricing and reimbursement pharmaceutical market access; emerging markets; developed markets; stakeholders; market access framework; escalating healthcare cost; pricing and reimbursement

Share and Cite

MDPI and ACS Style

Kumar, A.; Juluru, K.; Thimmaraju, P.K.; Reddy, J.; Patil, A. Pharmaceutical Market Access in Emerging Markets: Concepts, Components, and Future. J. Mark. Access Health Policy 2014, 2, 25302. https://doi.org/10.3402/jmahp.v2.25302

AMA Style

Kumar A, Juluru K, Thimmaraju PK, Reddy J, Patil A. Pharmaceutical Market Access in Emerging Markets: Concepts, Components, and Future. Journal of Market Access & Health Policy. 2014; 2(1):25302. https://doi.org/10.3402/jmahp.v2.25302

Chicago/Turabian Style

Kumar, Anuj, Karthaveerya Juluru, Phani Kishore Thimmaraju, Jayachandra Reddy, and Anand Patil. 2014. "Pharmaceutical Market Access in Emerging Markets: Concepts, Components, and Future" Journal of Market Access & Health Policy 2, no. 1: 25302. https://doi.org/10.3402/jmahp.v2.25302

APA Style

Kumar, A., Juluru, K., Thimmaraju, P. K., Reddy, J., & Patil, A. (2014). Pharmaceutical Market Access in Emerging Markets: Concepts, Components, and Future. Journal of Market Access & Health Policy, 2(1), 25302. https://doi.org/10.3402/jmahp.v2.25302

Article Metrics

Back to TopTop